1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Gaspari, Z.
Patthy, A.
Graf, L.
Perczel, A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
269
527
537
10.1046/j.0014-2956.2001.02685.x
11856311
Comparative structure analysis of proteinase inhibitors from the desert locust, Schistocerca gregaria.
2002
10.2210/pdb1kio/pdb
pdb_00001kio
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
3705.227
SERINE PROTEASE INHIBITOR I
Residues 57-91
L30R,K31M
1
syn
polymer
Schistocerca gregaria chymotrypsin inhibitor (SGCI)
no
no
EVTCEPGTTFKDKCNTCRCGSDGKSAACTRMACPQ
EVTCEPGTTFKDKCNTCRCGSDGKSAACTRMACPQ
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2001-12-12
1
1
2008-04-27
1
2
2011-07-13
1
3
2021-10-27
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGCI
PROTEINASE INHIBITOR PMP-C (NMR, 36 STRUCTURES)
SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGTI
RCSB
Y
RCSB
2001-12-03
REL
REL
Solid phase peptide synthesis, Fmoc strategy, Sequence naturally found in Schistocerca gregaria (desert locust)
sample
structures with acceptable covalent geometry,structures with the least restraint violations
100
10
2D NOESY
0
3.03
ambient
292
K
the structures are based on a total of 526 NMR distance restraints (150 long-range)
simulated annealing
3
closest to the average
2.8mM SGCI[L30R, K31M] NA
90% H2O/10% D2O
Brunger
refinement
X-PLOR
3.851
Brunger
structure solution
X-PLOR
3.851
500
Bruker
DRX
GLU
1
n
1
GLU
1
A
VAL
2
n
2
VAL
2
A
THR
3
n
3
THR
3
A
CYS
4
n
4
CYS
4
A
GLU
5
n
5
GLU
5
A
PRO
6
n
6
PRO
6
A
GLY
7
n
7
GLY
7
A
THR
8
n
8
THR
8
A
THR
9
n
9
THR
9
A
PHE
10
n
10
PHE
10
A
LYS
11
n
11
LYS
11
A
ASP
12
n
12
ASP
12
A
LYS
13
n
13
LYS
13
A
CYS
14
n
14
CYS
14
A
ASN
15
n
15
ASN
15
A
THR
16
n
16
THR
16
A
CYS
17
n
17
CYS
17
A
ARG
18
n
18
ARG
18
A
CYS
19
n
19
CYS
19
A
GLY
20
n
20
GLY
20
A
SER
21
n
21
SER
21
A
ASP
22
n
22
ASP
22
A
GLY
23
n
23
GLY
23
A
LYS
24
n
24
LYS
24
A
SER
25
n
25
SER
25
A
ALA
26
n
26
ALA
26
A
ALA
27
n
27
ALA
27
A
CYS
28
n
28
CYS
28
A
THR
29
n
29
THR
29
A
ARG
30
n
30
ARG
30
A
MET
31
n
31
MET
31
A
ALA
32
n
32
ALA
32
A
CYS
33
n
33
CYS
33
A
PRO
34
n
34
PRO
34
A
GLN
35
n
35
GLN
35
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
THR
8
A
N
THR
8
A
O
CYS
19
A
O
CYS
19
4
A
A
O
H
PHE
CYS
10
17
1.55
7
A
A
H
O
GLY
SER
20
25
1.50
8
A
A
H
O
GLY
CYS
7
19
1.59
10
A
A
H
O
GLY
CYS
7
19
1.59
1
A
ARG
18
0.313
SIDE CHAIN
1
A
ARG
30
0.250
SIDE CHAIN
2
A
ARG
18
0.242
SIDE CHAIN
2
A
ARG
30
0.292
SIDE CHAIN
3
A
ARG
18
0.195
SIDE CHAIN
3
A
ARG
30
0.284
SIDE CHAIN
4
A
ARG
30
0.317
SIDE CHAIN
5
A
ARG
18
0.214
SIDE CHAIN
5
A
ARG
30
0.245
SIDE CHAIN
6
A
ARG
18
0.314
SIDE CHAIN
6
A
ARG
30
0.222
SIDE CHAIN
7
A
ARG
18
0.180
SIDE CHAIN
7
A
ARG
30
0.316
SIDE CHAIN
8
A
ARG
18
0.197
SIDE CHAIN
8
A
ARG
30
0.233
SIDE CHAIN
9
A
ARG
18
0.118
SIDE CHAIN
9
A
ARG
30
0.203
SIDE CHAIN
10
A
ARG
18
0.285
SIDE CHAIN
10
A
ARG
30
0.215
SIDE CHAIN
1
A
LYS
13
45.83
-135.63
1
A
THR
16
-51.53
179.12
1
A
CYS
17
-168.75
88.24
1
A
ARG
18
-68.00
98.21
1
A
SER
25
-170.23
116.35
1
A
CYS
28
63.78
136.78
1
A
ARG
30
-155.37
-156.83
2
A
THR
8
-165.39
-33.79
2
A
THR
9
51.53
165.57
2
A
PHE
10
176.46
168.95
2
A
LYS
13
48.33
-102.97
2
A
THR
16
-52.64
-174.62
2
A
CYS
17
174.85
95.43
2
A
LYS
24
170.59
41.35
2
A
SER
25
-172.63
100.32
2
A
ALA
26
-104.63
-150.46
2
A
ALA
27
-147.28
-39.38
2
A
CYS
28
63.69
134.36
3
A
THR
3
176.60
25.53
3
A
ASP
12
-98.90
-82.69
3
A
LYS
13
-68.20
-102.41
3
A
THR
16
-76.00
-166.18
3
A
CYS
17
174.38
107.68
3
A
LYS
24
-149.98
43.16
3
A
SER
25
-172.06
109.72
3
A
CYS
28
63.72
135.93
3
A
ARG
30
73.93
122.81
3
A
MET
31
-165.18
-32.74
3
A
ALA
32
72.63
136.22
4
A
THR
3
158.97
-20.36
4
A
PHE
10
178.55
164.65
4
A
LYS
11
-58.64
-149.72
4
A
ASP
12
174.88
-26.40
4
A
LYS
13
138.92
-51.04
4
A
CYS
19
-34.24
129.20
4
A
LYS
24
-150.45
15.60
4
A
THR
29
-37.24
-89.66
4
A
ARG
30
-172.81
-47.21
4
A
MET
31
-16.35
-75.93
4
A
ALA
32
-148.98
-149.58
5
A
THR
8
-150.68
-30.40
5
A
THR
9
57.76
122.99
5
A
LYS
13
73.94
-76.84
5
A
CYS
14
-134.77
-35.55
5
A
ASN
15
-118.32
-169.20
5
A
CYS
19
69.48
106.29
5
A
THR
29
-51.41
-103.54
5
A
ARG
30
-179.36
34.43
5
A
MET
31
-55.52
-82.41
5
A
ALA
32
158.92
121.76
6
A
CYS
4
-43.77
169.11
6
A
LYS
13
64.49
-78.30
6
A
ARG
18
-44.21
108.82
6
A
THR
29
-55.16
-81.29
6
A
ARG
30
-77.04
-138.60
6
A
MET
31
178.67
69.22
7
A
LYS
13
59.42
-81.04
7
A
CYS
14
-157.55
18.60
7
A
LYS
24
48.33
23.34
7
A
MET
31
53.46
107.31
7
A
ALA
32
163.41
67.50
8
A
THR
8
-153.26
-33.69
8
A
THR
9
75.68
144.51
8
A
ASP
12
-130.15
-45.87
8
A
LYS
13
-125.55
-98.05
8
A
CYS
19
62.49
91.31
8
A
LYS
24
-150.53
51.02
8
A
CYS
28
74.85
138.62
8
A
ARG
30
70.54
82.47
8
A
ALA
32
67.52
135.20
9
A
LYS
13
-120.59
-75.54
9
A
THR
16
-58.49
174.11
9
A
CYS
17
-164.86
106.10
9
A
CYS
19
-35.59
107.97
9
A
LYS
24
-142.29
38.07
9
A
SER
25
-170.77
104.98
9
A
CYS
28
69.28
138.35
9
A
ARG
30
-120.23
-71.09
9
A
MET
31
179.46
-71.03
9
A
ALA
32
164.85
124.49
10
A
THR
8
-164.17
-18.11
10
A
THR
9
44.98
113.46
10
A
LYS
13
56.24
-107.67
10
A
ASN
15
-155.06
-154.29
10
A
THR
16
-117.36
-165.92
10
A
CYS
17
172.48
105.05
10
A
CYS
19
75.28
91.87
10
A
LYS
24
-140.90
21.46
10
A
CYS
28
62.85
133.12
10
A
ARG
30
72.88
109.29
10
A
MET
31
-136.80
-74.15
10
A
ALA
32
162.36
85.64
SOLUTION STRUCTURE OF THE SMALL SERINE PROTEASE INHIBITOR SGCI[L30R, K31M]
1
N
N
disulf
2.021
A
CYS
4
A
SG
CYS
4
1_555
A
CYS
19
A
SG
CYS
19
1_555
disulf
2.016
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
33
A
SG
CYS
33
1_555
disulf
2.022
A
CYS
17
A
SG
CYS
17
1_555
A
CYS
28
A
SG
CYS
28
1_555
HYDROLASE
specificity, protease inhibitor, modified specificity, HYDROLASE
SGP1_SCHGR
UNP
1
1
O46162
MKLALALCAAFLLVVLVQAEQECTPGQTKKQDCNTCNCTPTGVWACTRKGCPPHKREVTCEPGTTFKDKCNTCRCGSDGK
SAACTLKACPQK
57
91
1KIO
1
35
O46162
A
1
1
35
1
LEU
engineered mutation
ARG
30
1KIO
A
O46162
UNP
86
30
1
LYS
engineered mutation
MET
31
1KIO
A
O46162
UNP
87
31
2
anti-parallel
A
THR
8
A
THR
8
A
THR
9
A
THR
9
A
ARG
18
A
ARG
18
A
CYS
19
A
CYS
19